In Alzheimer's disease mice, exogenous IFN‐γ improved the neurological symptoms by attenuating the stimulation of β amyloid to microglia through promoting glycolysis by activating mTOR pathway.17 Here, IFNG is linked to early-onset autosomal dominant Alzheimer disease.